HALO Growth 100 · Sector S2
Longevity & Healthspan
GLP-1 leaders, gene-editing platforms, diagnostics-at-scale, biopharma compounders. Demographics writes the demand curve.
Equal-weight — 1d —
Cap-weighted — 1d —
Momentum (drift) — 1d —
Constituents — in this sector
Composite Index — since inception (Dec 30, 2025)
Three weighting variants of the same constituent basket, rebased to 1,000 at inception. EW = ticker-equal-weight with quarterly drift. CW = cap-weighted (10% cap; below ten names the cap is infeasible, so the sub-index is equal weight by construction) with semi-annual rebalance. MW = drift-only (1/N at inception, market does the tilting between rebalances). Click a legend entry to toggle its line.
Constituents
Every HALO 100 constituent tagged into this sector. Click a column header to sort (best to worst). Click a row to open the stock detail page in a new tab.
| Ticker | Company | Region | Last | 1d | 1w | 1m | 3m | 6m | 1y | CCY |
|---|---|---|---|---|---|---|---|---|---|---|
| ILMN | Illumina | NAM | 276.67 | -0.54% | -5.80% | +34.01% | +44.70% | +117.92% | +186.85% | USD |
| NTRA | Natera | NAM | 397.77 | -0.73% | -6.55% | +20.93% | +45.88% | +97.01% | +129.85% | USD |
| AMGN | Amgen | NAM | 417.57 | +0.65% | +3.62% | +10.66% | +17.54% | +19.37% | +43.34% | USD |
| LLY | Eli Lilly | NAM | 1182.62 | +0.28% | +3.46% | +6.00% | +2.61% | +27.23% | +38.70% | USD |
| GXI.DE | Gerresheimer | EUR | 29.10 | +1.54% | +2.46% | +3.12% | +0.28% | +37.65% | +1.46% | EUR |
| VRTX | Vertex Pharma | NAM | 507.00 | -0.60% | +0.70% | -1.64% | +6.44% | +15.21% | +22.21% | USD |
| REGN | Regeneron | NAM | 762.81 | +2.18% | +5.00% | -2.39% | +16.26% | +2.19% | +34.18% | USD |
| NVO | Novo Nordisk | EUR | 38.58 | -0.16% | +2.77% | -10.42% | -21.38% | +1.58% | -31.84% | USD |
| VKTX | Viking Therapeutics | NAM | 28.34 | -0.60% | -3.21% | -11.38% | -25.36% | -19.05% | -18.98% | USD |
| ZEAL.CO | Zealand Pharma | EUR | 234.80 | -1.34% | -11.60% | -15.60% | -21.47% | -18.61% | -53.00% | DKK |